Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1481-1482

  Fioravanti, Antonella ^a   Simonini, Gabriele ^b   Cantarini, Luca ^a   Generoso, Marta ^b   Galeazzi, Mauro ^a   Bacarelli, Maria Romana ^a   Cimaz, Rolando ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; IMMUNOGLOBULIN; OMENTIN; UNCLASSIFIED DRUG; VASPIN;

BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; LETTER; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOKINES; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GPI-LINKED PROTEINS; HUMANS; INFANT; ITALY; LECTINS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SERPINS;

EID: 84863633508     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1873-3     Document Type: Letter

References (10)

1. Lago F, Dieguez C, Gómez-Reino J, Gualillo O (2007) Adipokines as emerging mediators of immune response and inXammation. Nat Clin Pract Rheumatol 3:716-724
2. Senolt L, Polanská M, Filková M, Cerezo LA, Pavelka K, Gay S et al (2010) Vaspin and omentin: new adipokines diVerentially regulated at the site of inXammation in rheumatoid arthritis. Ann Rheum Dis 69:1410-1411
3. SchäZer A, Zeitoun M, Wobser H, Buechler C, Aslanidis C, Herfarth H (2007) Frequency and signiWcance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inXammatory bowel diseases. Cardiovasc Diabetol 6:3
4. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A et al (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102:10610-10615
5. Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364: 533-544
6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [published correction appears in Pediatrics. 2005;115:1118]. Pediatrics 114:1708-1733
7. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK (2004) Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 43:120-124
8. Takeshita S, Takabayashi H, Yoshida N (2006) Circulating adipo-nectin levels in Kawasaki disease. Acta Paediatr 95:1312-1314
9. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476
10. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J et al (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655-1661